For cardiology colleagues — please verify figures against the primary sources listed below before relying on them clinically.
Why this document matters
Acute pulmonary embolism has never had a dedicated ACC/AHA guideline. The 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults (Creager MA, Barnes GD, Giri J, et al.; published online in JACC, 19 February 2026) is a de novo document, developed and endorsed across ten societies. Its explicit premise is that PE care is uniquely multidisciplinary and crosses the emergency department, inpatient settings and outpatient clinics — which is precisely why it has historically been managed inconsistently.
The central change: five clinical categories
The guideline replaces the familiar low/intermediate/high-risk shorthand with five Acute PE Clinical Categories (A–E), plus subcategories, intended to sharpen severity definition, prognosis and treatment selection:
- Category A (subclinical) — can safely be discharged from the emergency department without admission.
- Category B (symptomatic, low clinical severity) — generally suitable for early discharge.
- Categories C–E (symptomatic with elevated severity scores) — admit, and consider escalation.
For the interventional community, the operative recommendations are that advanced therapies — systemic thrombolysis, catheter-directed thrombolysis, mechanical thrombectomy, surgical embolectomy — are reasonable in Category E1 and may be considered in Categories D1–2. Note the deliberate asymmetry in that language: this is a framework that legitimises catheter-based therapy without overselling it. The guideline's own evidence-gap section concedes that the categories themselves still require validation, and that predictors such as thrombus burden and RV enlargement metrics have yet to be integrated.
Two other points worth carrying into practice
Anticoagulation. Low-molecular-weight heparin is recommended over unfractionated heparin where initial parenteral therapy is needed. DOACs are recommended over vitamin K antagonists in patients eligible for oral anticoagulation, unless contraindicated. Anticoagulation should be continued beyond the initial 3–6 month phase after a first PE without a major reversible risk factor, or where a persistent risk factor exists.
PE response teams. A PERT is recommended to drive decisions on advanced intervention — drawing in vascular medicine, pharmacy, nursing, emergency medicine and cardiac surgery, alongside the patient and family.
Why it matters for central Gujarat patients
PE is the diagnosis we miss, not the one we mistreat. Three practical implications here:
- The categories are the transferable part. Mechanical thrombectomy devices are not universally available in this region, and cost is a real constraint. But categorisation costs nothing — a structured severity assessment at first contact is the step that changes outcomes most, and it is fully implementable at our centre and the peripheral clinics today.
- A PERT does not require new hardware. In our setting it can be a standing phone-tree agreement between cardiology, medicine, critical care and the referring physician. That alone would shorten the interval from CT pulmonary angiogram to a treatment decision.
- Post-surgical and post-partum PE is under-recognised locally. The guideline's risk-factor list — recent surgery, hospitalisation, immobility, pregnancy, oestrogens, trauma, cancer, thrombophilias — maps closely onto the patients who present late here with breathlessness after an operation.
- Category A and B guidance has a cost dimension. Safe early discharge in genuinely low-severity PE is not simply resource-rationing; it matters for families paying out of pocket.
Bottom line
Adopt the A–E categorisation for documentation and referral now; build an informal PERT pathway next; reserve catheter-based therapy for the high-severity categories where the guideline supports it, and be candid with families that the evidence base for intervention is still maturing.
Sources
- Full guideline — JACC
- Full guideline — Circulation
- ACC — first-ever guideline for treatment and management of acute PE (19 Feb 2026)
- JACC — A Field in Transition: Catheter-Based Therapy in the 2026 AHA/ACC Acute PE Guideline
- JACC — 2026 Acute Pulmonary Embolism Guideline-at-a-Glance
- ACC Acute PE Guideline Hub